Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-16

Clinical Trial Update: Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating physiologic parameters to study mechanism of action of the Lung Volume Reduction Coil in subjects with homogeneous emphysema…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lung Volume Reduction Coil

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Emphysema | Phase 2, Phase 3 | Status: COMPLETED